反式-N1-(4-(3-异丙基-2-甲基-2H-吲唑-5-基)嘧啶-2-基)-N4-(四氢-2H-吡喃-4-基)环己烷-1,4-二胺
CDK9,CDK8和CDK7抑制剂(LY2857785);反式-N1-(4-(3-异丙基-2-甲基-2H-吲唑-5-基)嘧啶-2-基)-N4-(四氢-2H-吡喃-4-基)环己烷-1,4-二胺;化合物LY2857785 CDK9,CDK8和CDK7抑制剂(LY2857785);反式-N1-(4-(3-异丙基-2-甲基-2H-吲唑-5-基)嘧啶-2-基)-N4-(四氢-2H-吡喃-4-基)环己烷-1,4-二胺;化合物LY2857785 展开
1619903-54-6
C₂₆H₃₆N₆O
448.60
中文名称 反式-N1-(4-(3-异丙基-2-甲基-2H-吲唑-5-基)嘧啶-2-基)-N4-(四氢-2H-吡喃-4-基)环己烷-1,4-二胺
中文别名 CDK9,CDK8和CDK7抑制剂(LY2857785);反式-N1-(4-(3-异丙基-2-甲基-2H-吲唑-5-基)嘧啶-2-基)-N4-(四氢-2H-吡喃-4-基)环己烷-1,4-二胺;化合物LY2857785
英文别名 LY2857785;LY-2857785;(1r,4r)-N1-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-N4-(tetrahydro-2H-pyran-4-yl)cyclohexane-1,4-diamine;4-N-[4-(2-methyl-3-propan-2-ylindazol-5-yl)pyrimidin-2-yl]-1-N-(oxan-4-yl)cyclohexane-1,4-diamine;BCP24053;BDBM50193097;s7511;SB18859;B8002;trans-N1-(4-(3-Isopropyl-2-methyl-2H-indazol-5-yl)pyrimidi;CID 78357764;LY2857785 (LY 2857785;1,4-Cyclohexanediamine, N1-[4-[2-methyl-3-(1-methylethyl)-2H-indazol-5-yl]-2-pyrimidinyl]-N4-(tetrahydro-2H-pyran-4-yl)-, trans-;trans-N1-(4-(3-Isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-N4-(tetrahydro-2H-pyran-4-yl)cyclohexane-1,4-diamine;Cyclin dependent kinase,LY 2857785,CDK,Apoptosis,LY2857785,Inhibitor,inhibit,LY-2857785;NCGC00390634-01;LY-2857785;LY 2857785;N1-[4-(3-isopropyl-2-methylindazol-5-yl)pyrimidin-2-yl]-N4-(oxan-4-yl)cyclohexane-1,4-diamine;CS-3336;NCGC00390634-02;BRD-K15382985-001-01-7;CCG-269222;AC-35707;1619903-55-7;SCHEMBL25994330;CHEMBL3940387;1619903-54-6;(1R,4R)-N1-[4-(3-ISOPROPYL-2-METHYLINDAZOL-5-YL)PYRIMIDIN-2-YL]-N4-(OXAN-4-YL)CYCLOHEXANE-1,4-DIAMINE;EX-A1714;phen-IA;SCHEMBL24977557;HY-12293;BS-15873;AKOS030526612
CAS No. 1619903-54-6
分子式 C₂₆H₃₆N₆O
分子量 448.60
象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group
搜索质检报告(COA)
搜索MSDS